C12N 2790/00011
Details
C12N2790/00011 (Details) appears on 1 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 9
- Assignees
- 10
- Inventors
- 28
- Latest grant
- 7 Jun 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Subgroups
Granted patents
- C12N 2790/10011PrionsIndexing code1
- C12N 2790/00021Viruses as suchIndexing code0
- C12N 2790/00022New viral proteins or individual genes, new structural or functional aspects ofIndexing code0
- C12N 2790/00023Virus like particles [vlp]Indexing code0
- C12N 2790/00031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2790/00032Use of virus as therapeutic agent, other than vaccineIndexing code0
- C12N 2790/00033Use of viral protein as therapeutic agent other than vaccineIndexing code0
- C12N 2790/00034Use of virus or viral component as vaccineIndexing code0
All 15 subgroupsShow fewer
- C12N 2790/00041Use of virus, viral particle or viral elements as a vectorIndexing code0
- C12N 2790/00051Methods of production or purification of viral materialIndexing code0
- C12N 2790/00061Methods of inactivation or attenuationIndexing code0
- C12N 2790/00071Demonstrated in vivo effectIndexing code0
- C12N 2790/00088For redistributionIndexing code0
- C12N 2790/12011Satellite virusesIndexing code0
- C12N 2790/14011ViroidsIndexing code0
Recent patents
- Compositions and methods for use in immunotherapy26 Dec 2024US 2024/0424090 A1Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Recombinant rna production30 Mar 2017US 2017/0088871 A1Consejo Superior de Investigaciones Cientificas
- Recombinant inactivated viral vector vaccine26 Feb 2015US 2015/0056245 A1Laboratorio Avi-Mex, S.A. De C.V.
- Method of Preparing Cells Susceptible to Transmissible Spongiform Encephalopathy and the Creation of TSE Persistently Infected Cells20 Sep 2012US 2012/0237969 A1Animal, Plant and Fisheries Quarantine and Inspect AGency
- Non-Integrating Retroviral Vector Vaccines31 May 2012US 2012/0135034 A1
Most cited
By later US patents